B
Boston Scientific Corporation BSX
$106.38 -$0.01-0.01% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 797.00M 674.00M 566.00M 469.00M 324.00M
Total Depreciation and Amortization 336.00M 325.00M 348.00M 306.00M 311.00M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -80.00M 220.00M 218.00M 61.00M 387.00M
Change in Net Operating Assets 233.00M -678.00M 324.00M 166.00M -209.00M
Cash from Operations 1.29B 541.00M 1.46B 1.00B 813.00M
Capital Expenditure -157.00M -187.00M -277.00M -179.00M -155.00M
Sale of Property, Plant, and Equipment -- -- 2.00M 0.00 --
Cash Acquisitions -1.01B -239.00M -3.42B -1.13B -48.00M
Divestitures -- -- -- -- --
Other Investing Activities 40.00M -74.00M -11.00M -121.00M -68.00M
Cash from Investing -1.13B -500.00M -3.70B -1.43B -271.00M
Total Debt Issued 0.00 1.56B 189.00M 22.00M 0.00
Total Debt Repaid -314.00M -1.31B 0.00 0.00 0.00
Issuance of Common Stock 32.00M 115.00M 28.00M 96.00M 26.00M
Repurchase of Common Stock -- -- -87.00M -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -58.00M -129.00M 84.00M -111.00M -2.00M
Cash from Financing -340.00M 233.00M 214.00M 7.00M 24.00M
Foreign Exchange rate Adjustments 2.00M 39.00M -9.00M 6.00M -1.00M
Miscellaneous Cash Flow Adjustments -- -- -1.00M -- 1.00M
Net Change in Cash -178.00M 313.00M -2.04B -412.00M 566.00M